<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03011931</url>
  </required_header>
  <id_info>
    <org_study_id>15-007568</org_study_id>
    <nct_id>NCT03011931</nct_id>
  </id_info>
  <brief_title>Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]</brief_title>
  <official_title>Simvastatin Metabolism as a Test for Celiac Disease Activity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Immunogenics, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Immunogenics, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the correlation between simvastatin metabolism by the enterocyte and the histologic
      state of the intestine in treated celiac disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A cross sectional design incorporating subjects with active celiac disease and healed celiac
      disease (based on clinically-obtained biopsies); and healthy individuals.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">February 2019</completion_date>
  <primary_completion_date type="Actual">January 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compare simvastatin metabolism with intestinal biopsies</measure>
    <time_frame>Within one month of visit</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Villous height and crypt depth</measure>
    <time_frame>Within 1 month of visit</time_frame>
    <description>As measured in intestinal biopsies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary interview</measure>
    <time_frame>At initial visit</time_frame>
    <description>To determine whether the patient is strictly adherent, mostly adherent or non-adherent to a gluten-free diet</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinalysis</measure>
    <time_frame>Prior to administration of simvastatin and at the 3-hour mark</time_frame>
    <description>Looking for traces of gluten peptides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serologic testing</measure>
    <time_frame>Prior to administration of simvastatin</time_frame>
    <description>tTG IgA titer level determination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DNA sampling</measure>
    <time_frame>Prior to administration of simvastatin</time_frame>
    <description>Genetic testing associated with celiac disease (DQ2 and DQ8)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Celiac Disease</condition>
  <arm_group>
    <arm_group_label>Simvastatin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Simvastatin tablet, 20 mg, one time by mouth</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Simvastatin</intervention_name>
    <description>20 mg Simvastatin given, Blood draw, Urine collection, Celiac serology testing, DNA sampling, Dietary review</description>
    <arm_group_label>Simvastatin</arm_group_label>
    <other_name>Zocor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Gluten-free diet for at least 1 year

          2. Clinical endoscopy within the past month

          3. Biopsies must show no villous atrophy or villous blunting

          4. Villous height to crypt depth (VHCD) ratio measurement should be 2.5:1 or greater

        Exclusion Criteria:

          1. 1st degree relative with Celiac Disease

          2. Positive tTG IgA, already on simvastatin or statin agent

          3. Unable to stop non-steroidal or anti-inflammatory drugs

          4. Prior history of GI surgery other than appendectomy or cholecystectomy

          5. Taking drugs know to inhibit or activate CYP3A4

          6. Unable to avoid food known to inhibit CYP3A4

          7. History of a reaction to statin drugs in the past

          8. Pregnant or nursing women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph A Murray, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>October 3, 2016</study_first_submitted>
  <study_first_submitted_qc>January 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2017</study_first_posted>
  <last_update_submitted>January 13, 2020</last_update_submitted>
  <last_update_submitted_qc>January 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celiac Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

